Illustrative estimate only - not verified by this sponsor. Contact the study team for actual compensation.
There is an unmet need to evaluate the impact of sub-clinical/mild COVID19 disease in the outpatient setting on prevalent and incident renal injury, as this data is currently unavailable. To capture the diversity of race/ethnic risk and COVID19 related municipal shelter-in-place guidance, the investigators will enroll COVID19-negative and COVID19-positive samples balanced by race/ethnicity from 3 different states, California, Michigan, and Illinois. Study endpoints will be assayed from urine samples mailed to the study team at 2, 6, and 12 months after their date of PCR test, with no requirement for these individuals to leave their homes to participate.
What happens when you apply
Reach out via phone or email to express interest
Brief call to discuss your health history
Medical screening at the research site
Begin your journey in the study
Inclusion Criteria: * Result of PCR-based COVID-19 test conducted in the past 4 weeks posted in EMR of participating AMC * Age 18 years or older at enrollment * Race/ethnicity, sex, age, and phone and/or home/email address provided Exclusion Criteria: * Failure of a candidate participant to give written informed consent to comply with the study protocol * Hospitalization up to 4 weeks after SARS-CoV-2 test * History of kidney transplant * History of dialysis
imaguineapig pulls live data from ClinicalTrials.gov (NIH/NLM).Illustrative estimate only - not verifiedPay estimates are approximate ranges based on study type and are not confirmed by sponsors — actual compensation may differ. Eligibility indicators use limited criteria (age, sex) only. We do not provide medical advice. Always contact the study team directly to confirm compensation, full eligibility, and risks before enrolling.